跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NRA-AMLODIPINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
NRA-AMLODIPINE
Authorized
STANDARD
NRA-AMLODIPINE
nora pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
5d414f22c239abb5
Company
nora pharma inc
Type
Standard
Approval Details
Approval Id
5d414f22c239abb5
Drug Approval Canada Name
NRA-AMLODIPINE
Product Name
NRA-AMLODIPINE
Status
Marketed
Status Date
2023-12-05
Original Market Date
2018-11-27
Din
02476452
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:28.08
Atc Original
C08CA01 AMLODIPINE
Atc Name
c 08 ca 01
Aig Number
0131437003
Company Name
nora pharma inc
Company Address
1565 Lionel-Boulet Blvd., Varennes, Quebec, Canada, J3X 1P7
Active Ingredients
AMLODIPINE (AMLODIPINE BESYLATE)
2.5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
5d414f22c239abb5
Type
Standard
Back to Health Canada Approvals